XKRX
00279K
Market cap1.19bUSD
Jul 09, Last price
20,200.00KRW
1D
-2.42%
1Q
-12.55%
Name
Amorepacific Group
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
AMOREPACIFIC Group, along with its various subsidiaries, engages in the worldwide development, promotion, and sale of cosmetics, personal care products, and related items. Their operations span key markets in Korea, across Asia, North America, and other international regions. The company's comprehensive product portfolio features an array of cosmetics, fine fragrances, specialized medical beauty solutions, advanced beauty devices, inner wellness products, extensive hair and body care ranges, dental hygiene offerings, and traditional tea culture goods. These are distributed through a multitude of distinguished brands, including AMORE pacific, Sulwhasoo, LANEIGE, Mamonde, Innisfree, ETUDE, SIENU, HERA, HOLITUAL, primera, IOPE, HANYUL, LIRIKOS, OUTRUN, EASY PEASY, Espoir, RAREKIND, STEADY, SOON+, ODYSSEY, MIREPA, BRO&TIPS!, BE READY, enuf proj, GOUTAL, fradore, AESTURA, makeON, VITAl BEAUTIE, cubeme, Ryo, mise en scene, Fresh Pop, LABO-H, Ayunche, amos, HAPPY BATH, illiyoon, FILLVOID, MEDIAN, Boncho Study, Pleasia, and OSULLOC. Furthermore, the group's business interests extend to the manufacturing and merchandising of pharmaceuticals, glass, green tea, detergents, and organic compounds. Other activities encompass the production, printing, and marketing of paper containers, providing product packaging services, crafting industrial machinery, and managing various facilities. Founded in 1945 and based in Seoul, South Korea, the corporation officially became AMOREPACIFIC Group in March 2011, having previously been known as PACIFIC Corporation.
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||